RNA-Based Biopharmaceuticals
Bound Therapeutics offers novel healthcare treatments by inactivating RNA molecules

Explore Our Technologies

RNA Therapeutics Platform

Unique drug design blocks pathogenic RNAs in multiple diseases, including cancer

Next-Generation Chemistry

Proprietary chemistry yields smaller, more specific, less toxic drugs

Disease-Specific Drug Delivery

Targeted delivery agent carries modified RNA drugs into disease cells, reducing toxicity to normal cells
@Bound012615 RT @LifeSciencesPA: Eric Wickstrom from #BoundTherapeutics is talking about a technology they developed to block cancer driving RNA in #bre…
@Bound012615 Bound Therapeutics has been selected as a finalist in the UC Science Center QED Program! twitter.com/JeffInnovation…
@Bound012615 Dr. Eric Wickstrom presented today at the LSPA Start-Up Stadium! twitter.com/KDLSPA/status/…